International Cancer Congress 2022

Background

ICC - 2022 is going to be the best stage for all the Oncologists, Researchers, Biomedical Engineers and Microbiologists to trade their insight identified with Cancer Research. This global meet International Cancer Congress–2022 will bring world’s leading professionals with interactive sessions stimulating the scientific environment for the attendees to exchange ideas. It will also provide a suitable platform for the budding scientists to nurture their skills with its special initiatives in cancer science.

The Conference's Organizing Committee is keeping a close eye on the COVID-19 pandemic and this event is being held in a hybrid format of both on-site and virtual versions, allowing those who are unable to attend in-person at the conference in India (Kolkata city) for a variety of reasons to participate. We believe that our decision will allow many more people to join us at ICC 2022.

We invite unpublished Research Papers from all basic, translational and clinical scientists (including postdocs and trainees), who are involed in and doing research on cancer-relevant areas, and who want to hear the latest developments in therapies targeting cancer and immune cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaboration. Our objective is to build scientific program, an ever deeper and that will highlight novel findings with new ways for you to meet in person and even engage together online.

Theme: Cancer2022

Authors are invited to submit their original and unpublished work. Topics of interest for submission are mentioned below (but not limited):

1. Biology of cancer
2. Cause and Types of Cancer
3. Cancer Imaging Techniques
4. Early diagnosis of Cancers–implementation, challenges and opportunities
5. Artificial intelligence to early detect cancer
6. Cancer grades and stages
7. Cancer prevention
8. Cancer management and research
9. Cancer and its relevance with other disease
10. Cancer Drugs
11. Case Reports on Cancer oncology
12. Cancer management & research
13. Organ specific Cancer
14. Cancer epidemiology
15. Cancer pathophysiology
16. Cancer research & clinical trials
17. Advances in cancer research and treatment
18. Personalized medicine: Genomics/epigenetics/proteomics
19. Stem cell transplant
20. Radio-Oncology/ Clinical Oncology

Publications

All accepted papers will be published in proceeding book of abstracts. Peer reviewed expanded versions of presented papers will be published in the Proceedings of Springer-Nature Proceedings/ Lecture Notes (SCOPUS indexed and having Impact factors). Selected good papers will be invited to forward in IEEE Journal of Biomedical and Health Informatics and the journal of Microsystem Technologies of Springer-Nature SCI indexed having impact factor=2.7.